Moreover, IL-6 was shown to be significantly over-expressed in pancreatic cancer tissue, and serum levels were significantly elevated in cachectic compared to non-cachectic patients with pancreatic cancer [48, 52, 53] and prostate cancer [49]. Here, IL6 is linked to familial pancreatic carcinoma.